Results 171 to 180 of about 36,099,759 (329)

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.

Kidney International, 2017
A. Tortajada, E. Gutiérrez, E. Goicoechea de Jorge, J. Anter, A. Segarra, M. Espinosa, M. Blasco, E. Román, H. Marco, L. Quintana, J. Gutiérrez, Sheila Pinto, M. López-Trascasa, M. Praga, S. Rodríguez de Córdoba   +14 more
semanticscholar   +1 more source

Truncated forms of human complement factor H [PDF]

, 1989
Marc Fontaine, M J Demares, Vesa Koistinen, Anthony J. Day, Christian Davrinche, Robert B. Sim, Jean Ripoche   +6 more
openalex   +1 more source

Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic cancer precursors

Molecular Oncology, EarlyView.
Combining melting curve analysis enhances the multiplexing capability of digital PCR. Here, we developed a 14‐plex assay to simultaneously measure single nucleotide mutations and amplifications of KRAS and GNAS, which are common driver genes in pancreatic cancer precursors. This assay accurately quantified variant allele frequencies in clinical samples
Junko Tanaka, Tatsuo Nakagawa, Yusuke Ono, Yoshio Kamura, Takeshi Ishida, Hidemasa Kawabata, Kenji Takahashi, Hiroki Sato, Andrew S. Liss, Yusuke Mizukami, Takahide Yokoi   +10 more
wiley   +1 more source

Pituitary Binding of³H-Labeled Sertoli Cell Factorin Vitro: A Potential Radioreceptor Assay for Inhibin* [PDF]

, 1984
L. Seethalakshmi, Anna Steinberger, E. Steinberger   +2 more
openalex   +1 more source

Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma

Molecular Oncology, EarlyView.
This study leveraged public datasets and integrative bioinformatic analysis to dissect malignant cell heterogeneity between relapsed and primary HCC, focusing on intercellular communication, differentiation status, metabolic activity, and transcriptomic profiles.
Wen‐Jing Wu, Jianchao Wang, Fuqing Chen, Xuefeng Wang, Bin Lan, Ruyi Fu, Hong Wen, Fangfang Chen, Wei Hong, Tian‐Yu Tang, Ying He, Gang Chen, Jianyin Zhou, Hai‐Long Piao, Di Chen, Shu‐Yong Lin   +15 more
wiley   +1 more source

Anti–Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases

Journal of Immunology, 2015
C. Blanc, C. Blanc, S. K. Togarsimalemath, S. Chauvet, S. Chauvet, M. L. Quintrec, B. Moulin, M. Büchler, T. Jokiranta, L. Roumenina, V. Frémeaux-Bacchi, M. Dragon-Durey   +11 more
semanticscholar   +1 more source

4030) A Study of House Design System in Accordance with Social Mass-Demand : Part VI. Method of Indication of Various Factors in Accordance with H. Es.

, 1966
Hiroshi Kawasaki
openalex   +2 more sources

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes. [PDF]

, 1983
Michael K. Pangburn, Robert D. Schreiber, John S. Trombold, Hans J. Müller‐Eberhard   +3 more
openalex   +1 more source

Comparing self‐reported race and genetic ancestry for identifying potential differentially methylated sites in endometrial cancer: insights from African ancestry proportions using machine learning models

Molecular Oncology, EarlyView.
Integrating ancestry, differential methylation analysis, and machine learning, we identified robust epigenetic signature genes (ESGs) and Core‐ESGs in Black and White women with endometrial cancer. Core‐ESGs (namely APOBEC1 and PLEKHG5) methylation levels were significantly associated with survival, with tumors from high African ancestry (THA) showing ...
Huma Asif, J. Julie Kim
wiley   +1 more source

Factor H-related 2 levels dictate FHR dimer composition. [PDF]

Sci Rep
Veuskens BRJ, Brouwer MC, van Mierlo G, Geissler J, van Leeuwen K, Derlagen M, Keijzer NCH, Hoogenboezem M, Kuijpers TW, Pouw RB.   +9 more
europepmc   +1 more source